IL-17 Inhibits Chondrogenic Differentiation of Human Mesenchymal Stem Cells

• Masahiro Kondo,

  Affiliations The First Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan, Pharmacology Research Laboratories I, Research Division, Mitsubishi Tanabe Pharma Corporation, Aoba-ku, Yokohama, Kanagawa, Japan

  ⨯
• Kunihiro Yamaoka,

  Affiliation The First Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan

  ⨯
• Koshiro Sonomoto,

  Affiliation The First Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan

  ⨯
• Shunsuke Fukuyo,

  Affiliation The First Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan

  ⨯
• Koichi Oshita,

  Affiliation Pharmacology Research Laboratories I, Research Division, Mitsubishi Tanabe Pharma Corporation, Aoba-ku, Yokohama, Kanagawa, Japan

  ⨯
• Yosuke Okada,

  Affiliation The First Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan

  ⨯
• Yoshiya Tanaka

  * E-mail: tanaka@med.uoeh-u.ac.jp

  Affiliation The First Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan

  ⨯